`Patent 6,331,415
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________
`
`GENZYME CORPORATION,
`
`Petitioner
`
`v.
`
`GENENTECH, INC. AND CITY OF HOPE,
`
`Patent Owners.
`
`Patent No. 6,331,415
`Appl. No. 07/205,419, filed June 10, 1988
`Issued: Dec. 18, 2001
`
`Title: Methods of Producing Immunoglobulins, Vectors
`and Transformed Host Cells for Use Therein
`____________________
`
`IPR Trial No. IPR2016-00383
`____________________
`
`_________________________________________________________________
`
`DECLARATION OF DARALYN J. DURIE IN SUPPORT OF PATENT
`OWNERS’ MOTION FOR PRO HAC VICE ADMISSION
`
`
`
`
`
` ActiveUS 151703625v.1
`
`Genzyme v. Genentech
`IPR2016-00383
`Genentech 2002
`
`
`
`
`
`I, Daralyn J. Durie, declare as follows:
`
`1.
`
`2.
`
`I am an attorney licensed to practice law in the State of California.
`
`I am a partner at the law firm Durie Tangri LLP and have litigated
`
`cases relating to patents for over 20 years.
`
`3.
`
`I am a member in good standing of the State Bar of California and the
`
`United States Court of Appeal for the Federal Circuit. I am also admitted to
`
`practice before the California Supreme Court, the United States Court of Appeals
`
`for the 3rd Circuit, the United States Court of Appeals for the 8th Circuit, the United
`
`States Court of Appeals for the 9th Circuit, the United States District Court of
`
`Colorado, and the United States District Courts in the Central, Eastern, Northern
`
`and Southern Districts of California.
`
`4.
`
`I am a member in good standing in all jurisdictions where I have been
`
`admitted to practice.
`
`5.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`6.
`
`I have never had an application denied for admission to practice
`
`before any court or administrative body.
`
`7.
`
`I have not had any sanctions or contempt citations imposed against me
`
`by any court or administrative body.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`
`ActiveUS 151703625v.1
`
`2
`
`
`
`
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`9.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq., and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`10.
`
`I have submitted a motion for Pro Hac Vice admission in IPR 2015-
`
`01624 on August 19, 2015 (motion pending).
`
`11.
`
`I have an established familiarity with the subject matter at issue in this
`
`proceeding. I have handled patent cases relating to recombinant antibodies for
`
`more than twelve years, including cases wherein U.S. Patent No. 6,331,415 (“the
`
`’415 patent”) was a patent-in-suit. In all of these cases involving the ‘’415 patent,
`
`I have represented Genentech and in some instances, City of Hope. In several of
`
`these cases, I have worked closely with Adam R. Brausa, back-up counsel for
`
`Patent Owners in this matter.
`
`12. Additionally, I have carefully reviewed and has developed extensive
`
`familiarity with the matters involved in and implicated by these proceedings,
`
`including the ’415 patent and its file history, the prior art presented in the petition,
`
`and the legal and factual issues raised by the Petitioners in this proceeding. As a
`
`result, I have acquired substantial understanding of the underlying legal and
`
`technological issues at stake in this proceeding.
`
`I hereby declare that all statements made herein of my own knowledge are
`
`
`ActiveUS 151703625v.1
`
`3
`
`
`
`
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements are made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`under Section 1001 of Title 18 of the United States Code and that such willful false
`
`statements may jeopardize the validity of U.S. Patent No. 6,331,415.
`
`
`
`Date: February 5, 2016
`
`
`
`
`
`
`
`Daralyn J. Durie
`
`Durie Tangri LLP
`217 Leidesdorff Street
`San Francisco, CA 94111
`
`
`
`
`ActiveUS 151703625v.1
`
`4
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
